Trials / Completed
CompletedNCT00742833
A Phase II Study of KUC-7483 in Patients With Overactive Bladder
A Randomized, Double Blind, Placebo Controlled, Phase II Study of KUC-7483 in Patients With Overactive Bladder
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- Sponsor
- Kissei Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the efficacy and safety of KUC-7483 in overactive bladder patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KUC-7483 | |
| DRUG | Placebo |
Timeline
- First posted
- 2008-08-28
- Last updated
- 2009-09-04
Locations
6 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00742833. Inclusion in this directory is not an endorsement.